Objectives
To assess the impact of a discharge diagnosis of critical illness polyneuromyopathy on health-related outcomes in a large cohort of patients requiring intensive care unit (ICU) admission.
Design
Retrospective cohort with propensity score matched analysis.
Setting
Analysis of a large multi-hospital database.
Patients
Adult ICU patients without pre-existing neuromuscular abnormalities and a discharge diagnosis of critical illness polyneuropathy and/or myopathy (CIPNM) along with adult ICU propensity matched control patients.
Interventions
None.
Measurements and Main Results
Of 3,567 ICU patients with a discharge diagnosis of CIPNM, we matched 3,436 of these patients to 3,436 ICU patients who did not have a discharge diagnosis of CIPNM. After propensity matching and adjusting for unbalanced covariates, we used conditional logistic regression and a repeated measures model to compare patient outcomes. Compared to patients without a discharge diagnosis of CIPNM, patients with a discharge diagnosis of CIPNM had fewer 28-day hospital free days (6 [0.1] vs 7.4 [0.1] days, p<0.0001), fewer 28-day ventilator free days (15.7 [0.2] vs 17.5 [0.2] days, p<0.0001), higher hospitalization charges (313,508 [4,853] vs 256,288 [4,470] dollars, p<0.0001), were less likely to be discharged home (15.3% vs 32.8%, p<0.0001), but had lower in-hospital mortality (13.7% vs 18.3%, p<0.0001).
Conclusions
In a propensity matched analysis of a large national database, a discharge diagnosis of CIPNM is strongly associated with deleterious outcomes including fewer hospital free days, fewer ventilator free days, higher hospital charges, and reduced discharge home, but also an unexpectedly lower in-hospital mortality. This study demonstrates the clinical importance of a discharge diagnosis of CIPNM and the need for effective preventive interventions.